Upgrade to SI Premium - Free Trial

Viridian Therapeutics (VRDN)

22.92 -0.04 (0.17%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/16/26)

Latest Headlines

Form 4 Viridian Therapeutics, For: Aug 19 Filed by: Tousignant Jennifer August 20, 2026 8:05 PM - SEC Filing Form SCHEDULE 13G Viridian Therapeutics, Filed by: Point72 Asset Management, L.P. August 20, 2026 4:15 PM - SEC Filing Form 144 Viridian Therapeutics, Filed by: Tousignant Jennifer August 19, 2026 2:31 PM - SEC Filing Form 4 Viridian Therapeutics, For: Aug 14 Filed by: Tripuraneni Radhika August 18, 2026 5:34 PM - SEC Filing Form SCHEDULE 13G/A Viridian Therapeutics, Filed by: Paradigm Biocapital Advisors LP August 14, 2026 4:32 PM - SEC Filing Form SCHEDULE 13G/A Viridian Therapeutics, Filed by: Kynam Capital Management, LP August 14, 2026 12:18 PM - SEC Filing Form SCHEDULE 13G Viridian Therapeutics, Filed by: PRICE T ROWE ASSOCIATES INC /MD/ August 14, 2026 10:40 AM - SEC Filing Form SCHEDULE 13G/A Viridian Therapeutics, Filed by: Deep Track Capital, LP August 14, 2026 8:33 AM - SEC Filing Form SCHEDULE 13G Viridian Therapeutics, Filed by: STATE STREET CORP August 7, 2026 11:13 AM - SEC Filing Viridian Reports Continuation of Massive Sulphides at Kraken Main; First Assays Pending August 6, 2026 3:02 PM - Globe NewsWire Viridian Therapeutic (VRDN) PT Lowered to $41 at Wedbush August 6, 2026 9:27 AM - StreetInsider Viridian Therapeutics, Inc. (VRDN) Misses Q2 EPS by 2c August 6, 2026 7:41 AM - StreetInsider Form 10-Q Viridian Therapeutics, For: Jun 30 August 6, 2026 7:32 AM - SEC Filing Viridian Therapeutics (VRDN) Added to Needham Conviction List August 6, 2026 7:28 AM - StreetInsider Form 8-K Viridian Therapeutics, For: Aug 06 August 6, 2026 7:05 AM - SEC Filing Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results August 6, 2026 7:01 AM - BizWire Form 4 Viridian Therapeutics, For: Jul 01 Filed by: CAIN CHRISTOPHER W. July 2, 2026 4:16 PM - SEC Filing Form 4 Viridian Therapeutics, For: Jul 01 Filed by: Ajer Jeffrey Robert July 2, 2026 4:16 PM - SEC Filing Form 4 Viridian Therapeutics, For: Jul 01 Filed by: Gheuens Sarah July 2, 2026 4:16 PM - SEC Filing Form 4 Viridian Therapeutics, For: Jul 01 Filed by: Moses Jennifer K. July 2, 2026 4:16 PM - SEC Filing Form 4 Viridian Therapeutics, For: Jul 01 Filed by: Morris Arlene July 2, 2026 4:15 PM - SEC Filing Form 4 Viridian Therapeutics, For: Jul 01 Filed by: Kiselak Tomas July 2, 2026 4:15 PM - SEC Filing Viridian Therapeutic (VRDN) PT Raised to $35 at RBC Capital June 30, 2026 6:48 AM - StreetInsider Viridian Therapeutic (VRDN) PT Raised to $43 at Wedbush June 29, 2026 12:25 PM - StreetInsider William Blair on Viridian Therapeutic (VRDN): 'We came away from the call incrementally more confident' June 29, 2026 12:25 PM - StreetInsider 4 Sizzling Biotech and Healthcare Companies Reporting Strategic Milestones June 29, 2026 9:51 AM - StreetInsider Viridian Therapeutic (VRDN) PT Raised to $40 at Stifel June 29, 2026 9:50 AM - StreetInsider Wells Fargo Upgrades Viridian Therapeutic (VRDN) to Overweight June 29, 2026 9:43 AM - StreetInsider Truist Reiterates Buy Rating on Viridian Therapeutic (VRDN) Following Veligrotug's FDA approval June 29, 2026 9:28 AM - StreetInsider UBS Reiterates Buy Rating on Viridian Therapeutic (VRDN) June 29, 2026 8:39 AM - StreetInsider Comcast, Viridian Therapeutics jump premarket; Doximity slips June 29, 2026 7:54 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on Viridian Therapeutic (VRDN) June 29, 2026 7:09 AM - StreetInsider Form 8-K Viridian Therapeutics, For: Jun 26 June 29, 2026 6:02 AM - SEC Filing Viridian Therapeutic (VRDN) Reiterated at Market Outperform by Citizens: Lumvoa Approved June 29, 2026 4:47 AM - StreetInsider FDA approves Viridian's Lumvoa for thyroid eye disease June 26, 2026 6:00 PM - StreetInsider Viridian Therapeutics Announces U.S. FDA Approval and Launch of Lumvoa™ (veligrotug-vvze) for the Treatment of Thyroid Eye Disease June 26, 2026 6:00 PM - BizWire Form SCHEDULE 13G Viridian Therapeutics, Filed by: Paradigm Biocapital Advisors LP June 26, 2026 4:05 PM - SEC Filing Viridian Metals Commences 2026 Diamond Drill Program at the Kraken June 9, 2026 9:01 AM - Globe NewsWire Full Article List